Atenolol clinical uses
Pro Research Analysisby 
Searched over 200M research papers
Atenolol Clinical Uses in Hypertension and Cardiovascular Disease
Atenolol is a selective beta-1 adrenergic receptor blocker widely used to manage various cardiovascular conditions. Its primary clinical use is in the treatment of hypertension, where it effectively lowers blood pressure in patients of all ages, including the elderly and pregnant women with hypertension-related complications 1246. Atenolol is also commonly prescribed for stable angina pectoris, where it reduces the frequency of anginal attacks and improves exercise tolerance 14.
Atenolol for Myocardial Infarction and Secondary Prevention
Atenolol plays a significant role in the management of acute myocardial infarction (heart attack). Early intervention with intravenous atenolol, followed by oral maintenance therapy, has been shown to reduce the recurrence of infarction and lower cardiovascular mortality rates 17. Long-term use of atenolol in patients with a history of myocardial infarction or hypertension is associated with reduced mortality from cardiovascular disease 17. However, evidence suggests that starting with oral atenolol once the patient is stable may be preferable to early intravenous administration, as the latter can be associated with more complications such as heart failure and shock .
Atenolol in Arrhythmias and Alcohol Withdrawal
Atenolol is used to prevent the recurrence of supraventricular arrhythmias, especially after initial control is achieved with intravenous administration . Additionally, atenolol has demonstrated benefits in managing symptoms of alcohol withdrawal syndrome, including reducing the need for other sedative medications and shortening hospital stays .
Atenolol Use in Pregnancy-Related Hypertension
Atenolol has been studied for its effectiveness in treating gestosis (pregnancy-induced hypertension). It is particularly beneficial for pregnant women with a hyperkinetic type of circulation, and careful assessment of hemodynamic type is recommended for optimal drug selection 16.
Atenolol for Infantile Hemangiomas
Beyond cardiovascular uses, atenolol has emerged as an effective treatment for infantile hemangiomas (IHs), which are common benign vascular tumors in infants. Studies show that oral atenolol is highly effective, with response rates above 90%, and is associated with fewer severe side effects compared to propranolol, the traditional treatment 89. Most side effects are mild, and life-threatening complications are rare, making atenolol a promising alternative for pediatric patients 89.
Other Investigational and Niche Uses
Atenolol is under investigation for potential use in preventing osteoporosis in postmenopausal women, though current evidence in animal models suggests only modest effects on bone health . Its chemical properties also make it of interest in some industrial applications, such as water treatment, but these are not related to clinical practice .
Safety and Tolerability
Atenolol is generally well tolerated, with a lower incidence of central nervous system side effects compared to less selective beta-blockers like propranolol, due to its low lipid solubility and limited brain penetration 124. Some patients may experience mild fatigue or minor metabolic changes, but serious adverse effects are uncommon 1489.
Conclusion
Atenolol is a well-established medication with proven effectiveness in treating hypertension, angina, arrhythmias, and for secondary prevention after myocardial infarction. It is also effective for infantile hemangiomas and has a favorable safety profile compared to other beta-blockers. Its use should be tailored to individual patient needs, with careful monitoring and follow-up to ensure optimal outcomes.
Sources and full results
Most relevant research papers on this topic